Skip to main content
Premium Trial:

Request an Annual Quote

Link Technologies Licenses Agilent's RNA Monomers

NEW YORK (GenomeWeb News) – Link Technologies has licensed Agilent Technologies' RNA monomers technology, the Scottish company said today.

Link Technologies said it will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.

The company makes reagents for oligonucleotide synthesis and modification, and it offers a variety of products including phosphoramidites, solid supports, modifiers, labels, bioconjugation and oligo-immobilisation products.

Financial terms of the agreement were not released.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.